Expectancy in placebo-controlled trials of psychedelics: if so, so what?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expectancy in placebo-controlled trials of psychedelics: if so, so what?
Authors
Keywords
-
Journal
PSYCHOPHARMACOLOGY
Volume 239, Issue 10, Pages 3047-3055
Publisher
Springer Science and Business Media LLC
Online
2022-09-05
DOI
10.1007/s00213-022-06221-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The challenges ahead for psychedelic ‘medicine’
- (2022) Suresh Muthukumaraswamy et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials
- (2022) Jacob S. Aday et al. PSYCHOPHARMACOLOGY
- Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
- (2021) L. S. Kaertner et al. Scientific Reports
- Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research
- (2021) Sara J. Tai et al. Frontiers in Psychiatry
- Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?
- (2021) Robin L Carhart-Harris et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder
- (2021) Matt Butler et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Ten Practical Recommendations for Improving Blinding Integrity and Reporting in Psychotherapy Trials
- (2021) David Mataix-Cols et al. JAMA Psychiatry
- Blinding and expectancy confounds in psychedelic randomized controlled trials
- (2021) Suresh D. Muthukumaraswamy et al. Expert Review of Clinical Pharmacology
- Who is blind in psychedelic research? Letter to the editor regarding: blinding and expectancy confounds in psychedelic randomized controlled trials
- (2021) Eduardo Ekman Schenberg Expert Review of Clinical Pharmacology
- New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy
- (2021) Tehseen Noorani et al. Frontiers in Psychiatry
- A narrative synthesis of research with 5-MeO-DMT
- (2021) Anna O Ermakova et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Placebo effects and neuromodulation for depression: a meta-analysis and evaluation of shared mechanisms
- (2021) Matthew J. Burke et al. MOLECULAR PSYCHIATRY
- Caution at psychiatry’s psychedelic frontier
- (2021) Matthew J. Burke et al. NATURE MEDICINE
- Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial
- (2021) James Rucker et al. BMJ Open
- Placebo and Nocebo Effects
- (2020) Luana Colloca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tripping on nothing: placebo psychedelics and contextual factors
- (2020) Jay A. Olson et al. PSYCHOPHARMACOLOGY
- Historic psychedelic drug trials and the treatment of anxiety disorders
- (2020) Neil M. Weston et al. DEPRESSION AND ANXIETY
- The Current Status of Psychedelics in Psychiatry
- (2020) David Nutt et al. JAMA Psychiatry
- Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies
- (2020) Joost J. Breeksema et al. CNS DRUGS
- So near yet so far: why won’t the UK prescribe medical cannabis?
- (2020) David Nutt et al. BMJ Open
- Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies
- (2020) Kristoffer A. A. Andersen et al. ACTA PSYCHIATRICA SCANDINAVICA
- Psychedelics in Psychiatry—Keeping the Renaissance From Going Off the Rails
- (2020) David B. Yaden et al. JAMA Psychiatry
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Leveraging the Shared Neurobiology of Placebo Effects and Functional Neurological Disorder: A Call for Research
- (2019) Matthew J. Burke et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Why all randomised controlled trials produce biased results
- (2018) Alexander Krauss ANNALS OF MEDICINE
- Emerging evidence for antidepressant actions of anesthetic agents
- (2018) Scott C. Tadler et al. Current Opinion in Anesthesiology
- Psychedelics and the essential importance of context
- (2018) Robin L Carhart-Harris et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Open label placebo: can honestly prescribed placebos evoke meaningful therapeutic benefits?
- (2018) Ted J Kaptchuk et al. BMJ-British Medical Journal
- Psychiatry & the psychedelic drugs. Past, present & future
- (2017) James J.H. Rucker et al. NEUROPHARMACOLOGY
- Specifying the effects of physician's communication on patients’ outcomes: A randomised controlled trial
- (2017) Mara van Osch et al. PATIENT EDUCATION AND COUNSELING
- Psychedelics in the treatment of unipolar mood disorders: a systematic review
- (2016) James JH Rucker et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Sham Surgery in Orthopedics: A Systematic Review of the Literature
- (2016) Adriaan Louw et al. PAIN MEDICINE
- Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis
- (2014) T. A. Furukawa et al. ACTA PSYCHIATRICA SCANDINAVICA
- Pragmatic design in randomized controlled trials
- (2014) M. Purgato et al. PSYCHOLOGICAL MEDICINE
- A role for placebo therapy in psychogenic movement disorders
- (2013) Karen S. Rommelfanger Nature Reviews Neurology
- Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
- (2012) Teri S Krebs et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity
- (2010) Ben Colagiuri Clinical Trials
- CONSORT 2010 changes and testing blindness in RCTs
- (2010) Kenneth F Schulz et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started